Soho-Yiming Pharmaceuticals

Hebei Soho-Yiming Pharmaceuticals is a leading Chinese pharmaceutical company specializing in the development and large-scale synthesis of peptide-based active pharmaceutical ingredients (APIs) and finished drug products. The company has established a comprehensive technology platform for solid-phase and liquid-phase peptide synthesis, allowing it to supply a wide range of critical medications globally. Its portfolio includes key treatments such as oxytocin for postpartum hemorrhage, terlipressin for variceal bleeding, and desmopressin for diabetes insipidus. Soho-Yiming operates state-of-the-art GMP-certified manufacturing facilities and maintains a strong presence in both the domestic Chinese market and international export markets. The company is recognized for its technical expertise in complex peptide chemistry and serves as a vital supplier to the global healthcare industry.